United States · 
Who invested in XyloCor Therapeutics?
XyloCor Therapeutics's investors include EQT Life Sciences, Longwood Fund and EQT.
United States · Series B startup
Who invested in XyloCor Therapeutics
Funding summaryUpdated 26 Oct 2026
$68Mraised across 1 round since 2025, from 1 source
- Latest round
- Series B, $68MFeb 2025
- Investors
- 3
The rounds
- Feb 2025
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists XyloCor Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about XyloCor Therapeutics
How much has XyloCor Therapeutics raised?
XyloCor Therapeutics has raised $68M across 1 round since 2025.
When did XyloCor Therapeutics last raise?
XyloCor Therapeutics's most recent round was a Series B of $68M in Feb 2025.
What was XyloCor Therapeutics's biggest round?
Its most recent round, $68M in Feb 2025, is also its largest on record.
Who backed XyloCor Therapeutics first?
XyloCor Therapeutics's first round on record, in Feb 2025, was backed by EQT Life Sciences, Longwood Fund and EQT.
What stage is XyloCor Therapeutics at?
XyloCor Therapeutics's latest named round is a Series B, in Feb 2025.
Where is XyloCor Therapeutics based?
XyloCor Therapeutics is based in the United States.
Companies like XyloCor Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.